sun pharmaceutical


Sun Pharma shares gain 4%; m-cap rises by Rs 2,384 cr

Jun 13 2018

Shares of Sun Pharmaceutical Industries today gained nearly 4 per cent after the company received EIR from the US health regulator for its Halol facility in Gujarat.

Sun Pharma says US FDA clears Halol plant

Jun 12 2018

India’s largest drugmaker Sun Pharmaceutical Industries Ltd said the US FDA cleared its Halol drug plant, which had been under supply restrictions due to quality control failures.

USFDA for voluntary action by Sun Pharma's on Halol plant observations

Jun 08 2018

USFDA has said it found objectionable conditions at Sun Pharmaceutical Industries' Halol plant in Gujarat but did not recommend any action against the company.

Sun Pharma gets USFDA nod for plaque psoriasis drug

Mar 21 2018

Sun Pharmaceutical Industries announced that it has received approval from the US FDA for Ilumya (tildrakizumab-asmn) drug for the treatment plaque psoriasis.

China's Tasly to list biotech arm in $1 billion Hong Kong IPO

Mar 05 2018

Tasly is planning to list its biopharma unit in Hong Kong to raise about $1 billion, in what is likely to be the largest biotech float in the city this year.

Sun Pharma gets 3 observations from USFDA for Halol plant

Feb 23 2018

Sun Pharmaceutical Industries said the US health regulator has issued three observations after inspecting its Halol facility in Gujarat.

Sun Pharmaceutical scrip dips 3 percent after Q3 results

Feb 14 2018

Shares of Sun Pharmaceutical Industries fell nearly 3 percent after the company reported 75 percent dip in its consolidated net profit for the Q3 ended December 2017.

Sun Pharma Q3 profit dips 75 percent to Rs 365 crore

Feb 14 2018

Sun Pharmaceutical Industries reported 75.17 percent dip in its consolidated net profit at Rs 365.39 crore for the third quarter ended December 31, 2017-18.

Sun Pharma posts profit dive on U.S. pricing pressure

Nov 14 2017

Sun Pharmaceutical Industries reported a 59 percent plunge in second-quarter profit, hurt by generics pricing pressure in the United States.

USFDA approves Sun Pharma's generic ezetimibe tablets

Jun 13 2017

Sun Pharmaceutical Industries said that one of its wholly owned subsidiaries has received final approval from USFDA for its generic version of ezetimibe tablets.

Indian Markets


    35,470.35 219.25   (-0.61 %)

    10,762.45 59.40   (-0.55 %)

Global Markets


Stocks In News



Mulls 1:1 Bonus Share Issue


To Issue 1:10 Bonus Shares; Record Date At July 11


Approved Bonus Issue Of 1:2; Record Date At June 27


Arm Buys Under-Construction Asset For Rs 234 Cr In Indore At Auction

Brownfield Acquisition To Add Approx. 1.1 Mn Sq. Ft. To Co's Retail Portfolio


Co In Pact To Buy 95% Of Climate Tech Pty, Australia

Deal Size Stands At Rs 201-211 Cr In Valuation


JLR Investor Presentation:

Have Exciting Products, Plans In The Pipeline To Generate Sustainable Growth

Aiming For A 4-7% EBIT Margin Over Medium Term, Will Invest 4.5 Bn GBP In FY19-21

Aiming For A 7-9% EBIT Margin Over Long Term

Long Term Investment Pegged At 12-13% Of Revenue

Retail Volume Grew By 1.7% & Revenue Grew By 6% In FY18

Also Launched Jaguar I-Pace As Co's First All Battery Electric Vehicle


To Set Up 5 Lk KL/Annum Plant At Visakhapatnam For Rs 1,785 Cr

To Set Up 6 Lk KL/Annum Plant In Mysore For Rs 2,300 Cr

Co's International Business Did Not Perform Well In FY18

Economy & Inflated Currency Hit Co's Egyptian Operations


To Launch Generic Tadalafil After Filing ANDA With USFDA


Sterile Drug Product Manufacturing Facility In Bengaluru Receives EIR From USFDA

USFDA's Pre-Approval & Inspection Of Facility Done In April & May 2018

EIR Notifies That The Inspection Stands Closed

Co Committed To Global Standards Of Quality & Compliance


Dr Reddy's Loses Patent Case With Eli Lilly Over Alimta

Co Cannot Launch Its Alternative Salt Forms Until The Eli Lilly Patent Expires

The U.S. District Court For The Southern District Of Indiana Ruled In Favour Of Lilly

The Eli Lilly Patent Expires In May 2022

twitter @BTVI